1 "Treatment of idiopathic nephrotic syndrome with cyclosporin A in children" 35 (35): S31-S36, 1991
2 "The treatment of minimal change nephrotic syndrome:lessons learned from multicentre co-operative studies" 150 : 380-387, 1991
3 "The new immunosuppressive era" 70 : 1-19, 1999
4 "Rational design of biologically active peptides:inhibition of T cell activation through interference with CD4 function" 13 : 456-461, 2000
5 "Pharmacokinetics of cyclosporine A in patients with nephrotic syndrome" 20 : 529-535, 1988
6 "One-center experience with cyclosporine in refractory nephrotic syndrome in children" 13 : 26-32, 1999
7 "Low-dose short-term cyclosporine versus etretinate in psoriasis:improvement of skin,nail,and joint involvement" 32 : 78-88, 1995
8 "Long-term results of cyclosporine-induced remission of relapsing nephrotic syndrome in children" 38 : 307-318, 1997
9 "Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome Collaborative Group of the Societe de Nephrologie" 45 : 1446-1456, 1994
10 "Long-term renal effects of low-dose cyclosporine in uveitis-treated patients:follow-up study" 13 : 2962-2968, 2002
1 "Treatment of idiopathic nephrotic syndrome with cyclosporin A in children" 35 (35): S31-S36, 1991
2 "The treatment of minimal change nephrotic syndrome:lessons learned from multicentre co-operative studies" 150 : 380-387, 1991
3 "The new immunosuppressive era" 70 : 1-19, 1999
4 "Rational design of biologically active peptides:inhibition of T cell activation through interference with CD4 function" 13 : 456-461, 2000
5 "Pharmacokinetics of cyclosporine A in patients with nephrotic syndrome" 20 : 529-535, 1988
6 "One-center experience with cyclosporine in refractory nephrotic syndrome in children" 13 : 26-32, 1999
7 "Low-dose short-term cyclosporine versus etretinate in psoriasis:improvement of skin,nail,and joint involvement" 32 : 78-88, 1995
8 "Long-term results of cyclosporine-induced remission of relapsing nephrotic syndrome in children" 38 : 307-318, 1997
9 "Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome Collaborative Group of the Societe de Nephrologie" 45 : 1446-1456, 1994
10 "Long-term renal effects of low-dose cyclosporine in uveitis-treated patients:follow-up study" 13 : 2962-2968, 2002
11 "Long-term clinical and pathological effects of cyclosporin in children with nephrosis" 14 : 214-217, 2000
12 "Long-term ciclosporin treatment in children with steroid- dependent nephrotic syndrome" 7 : 249-252, 1993
13 "Long- term reatment of minimal-change nephrotic syndrome with cyclosporin:a control biopsy study" 3 : 733-737, 1988
14 "Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels(C2)" 73 : 953-959, 2002
15 "Effect of grapefruit juice on cyclosporin A pharmacokinetics in pediatric renal transplant patients" 4 : 313-321, 2000
16 "Cyclosporine treatment of nephrotic syndrome in children" 20 : 269-274, 1988
17 "Cyclosporine therapy for steroid-resistant nephrotic syndrome. A controlled study" 142 : 985-988, 1988
18 "Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation" Kidney Int 938-944, 1998
19 "Cyclosporine in the treatment of idiopathic nephrosis" 5 : 1049-1056, 1994
20 "Cyclosporin pharmacokinetics following administration of capsules and Neoral in paediatric patients with lupus nephritis" 44 : 125-127, 1997
21 "Cyclosporin monitoring based on C2 sampling" 73 : 840-841, 2002
22 "Cyclosporin for atopic dermatitis in children" 203 : 3-6, 2001
23 "Cyclosporin A in nephrotic syndrome of childhood--a 14 month experience" 7 : 69-72, 1986
24 "Current immunosuppressant regimens:considerations for critical care" 7 : 242-250, 2001
25 "Conversion and pharmacokinetic studies of a microemulsion formulation of cyclosporine in pediatric liver transplant patients" 62 : 1068-1071, 1996
26 "Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin(Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month" 24 : 479-486, 2002
27 "Comparison of four different cyclosporine immunoassays in heart and kidney transplant recipients" 12 : 547-553, 1990
28 "Comparison of bioavailability and metabolism with two commercial formulations of cyclosporine a in rats" 30 : 658-662, 2002
29 "Comparison between pre- and posttreatment clinical and renal biopsies in children receiving low dose ciclosporine-A for 2 years for steroid-dependent nephrotic syndrome" 52 : 19-24, 1999
30 "Comparative pharmacokinetic study of neoral versus Sandimmun in Japanese stable renal allograft recipients" 33 : 2541-2544, 2001
31 "Clinical benefit of monitoring cyclosporine C2 and C4 in long-term liver transplant recipients" 34 : 1535-1537, 2002
32 "Ciclosporin treatment in children with steroid-dependent nephrotic syndrome" 4 : 474-477, 1990
33 "Case reports of low dose cyclosporine. A therapy in adult minimal change nephrotic syndrome" 30 : 430-435, 2001
34 "C2 monitoring strategy for optimising cyclosporin immunosuppression from the Neoral formulation" 15 : 279-290, 2001
35 "A preliminary pharmacokinetic study of cyclosporine A in 10 Japanese renal transplant patients" 25 : 438-442, 1987
36 "A pharmacokinetic study of Neoral in childhood steroid-dependent nephrotic syndrome" 16 : 154-155, 2001